ArticleBMJ open2025

Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial.

Zhe Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.